What is XOMA Royalty Corp. (XOMA)?

XOMA Royalty Corp. (XOMA) is a stock in the Healthcare sector, Biotechnology industry. View full analysis on Stocks360.

What is the current price of XOMA?

The current price of XOMA is $40.17. Prices are updated in real time on Stocks360.

What is XOMA's price-to-earnings (PE) ratio?

XOMA's trailing twelve-month PE ratio is 24.35, based on current price and earnings per share data available on Stocks360.

What is XOMA's market capitalization?

XOMA's market capitalization is $710,155,066.00, placing it in the small-cap tier.

XOMA Royalty Corp. (XOMA)

Stock analysis · NASDAQ · Healthcare · Biotechnology

$40.17

Market Cap

$710.16M

PE (TTM)

24.35

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.86

Day Range

$39.87 – $43.53

52-wk Range

$22.29 – $45.22

Avg Volume

N/A

Volume

0.00

XOMA Royalty Corp. (XOMA) is a publicly traded company in the Healthcare sector. Latest price: $40.17. Market cap $710.16M. Trailing PE 24.35. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-31 · $32.98 2026-07-21 · $40.17 (+21.80%)

Earnings

Most Recent

May 12, 2026

EPS $0.17 vs est. $0.19

Missed by $0.02

Proprietary Signals

Signal snapshot temporarily unavailable.

About XOMA Royalty Corp.

XOMA Royalty Corp. functions as a specialist in aggregating biotechnology royalties, with its operations extending across Europe, the United States, and the Asia Pacific region. The company is dedicated to fostering advancements in human health by collaborating with biotechnology firms. Its core business model involves acquiring the anticipated future economic benefits, such as royalties and milestone payments, associated with pre-market therapeutic candidates that have already been licensed to pharmaceutical or biotechnology firms. The firm focuses its investments on early to mid-stage clinical assets, typically those in Phase 1 and 2 trials, selected for their robust commercial potential and because they are licensed to development partners. Its extensive portfolio currently encompasses around 70 distinct assets. The parent company, XOMA Corporation, established in 1981, has its main office in Emeryville, California.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	24.35×
P/S (TTM)	19.60×
P/B	4.23×
P/FCF (TTM)	107.05×
EV / EBITDA	14.76×
EV / Sales	20.44×
Earnings Yield	6.59%
Free Cash Flow Yield	0.93%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$740.43M
Revenue (TTM)	$36.23M
Net Income (TTM)	$46.83M
Free Cash Flow (TTM)	-$1.76M
Net Debt	$30.27M
Working Capital	$85.67M
Gross Margin	93.29%
Operating Margin	13.73%
Net Margin	86.97%
Return on Equity	30.21%
Return on Invested Capital	1.94%